Zepp Health (NYSE:ZEPP) Upgraded by Wall Street Zen to Hold Rating

Key Points

• Zepp Health (NYSE:ZEPP) has been upgraded to a "hold" rating by Wall Street Zen in a recent report.
• Separately, Fundamental Research set a price target of $13.87 on Zepp Health and assigned a "buy" rating.
• As of Friday, Zepp Health's stock opened at $33.49 with a market capitalization of $485.61 million and an earnings per share (EPS) of -$1.13 reported in its last quarterly earnings.

Wall Street Zen upgraded shares of Zepp Health (NYSE:ZEPP - Free Report) to a hold rating in a report released on Saturday.

Separately, Fundamental Research set a $13.87 target price on Zepp Health and gave the stock a "buy" rating in a report on Tuesday, April 22nd.

Zepp Health Trading Down 4.6%

Zepp Health stock traded down $1.62 during trading on Friday, hitting $33.49. The company's stock had a trading volume of 271,243 shares, compared to its average volume of 536,256. The stock's fifty day moving average is $11.06 and its 200 day moving average is $5.67. Zepp Health has a 1-year low of $2.13 and a 1-year high of $38.59. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.78 and a current ratio of 1.10. The stock has a market capitalization of $485.61 million, a price-to-earnings ratio of -6.93 and a beta of 1.11.

Zepp Health (NYSE:ZEPP - Get Free Report) last issued its quarterly earnings results on Monday, May 19th. The company reported ($1.13) earnings per share (EPS) for the quarter. The firm had revenue of $38.54 million for the quarter. Zepp Health had a negative net margin of 38.81% and a negative return on equity of 24.19%.

About Zepp Health

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.